Income statement
EUR
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 876M | 1.0B | 1.0B | 969M | 937M |
| Gross Profit | 18M | 96M | 101M | 93M | 100M |
| Operating Income | 500K | 8M | 16M | 17M | 28M |
| EBITDA | 16M | 22M | 19M | 29M | 39M |
| Net Income | -2M | 5M | 10M | 11M | 20M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Cyclical
Live Price
Offline$12.17
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 → Apr 6, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 198 bars · Jun 23, 2025 → Apr 6, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Kamux Oyj (KMUXF) is a Consumer Cyclical stock with a market cap of $485.26M and listed on OTC. The stock last traded around $12.17 and up 0.0% across the available one-year price window (Jun 23, 2025 → Apr 6, 2026). Baseline metrics include revenue growth of -13.3%, EPS growth of -148.1%, a dividend yield of 4.3%. What stands out right now is revenue -13.3%, EPS -148.1%, free cash flow +4180.3% with operating margin 0.1% and ROIC 0.3%. The dividend matters to the case here, with a current yield around 4.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines KMUXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
KMUXF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
KMUXF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for KMUXF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$937.4M
-3.2% YoY
FY Net Income
$19.6M
+81.5% YoY
Free Cash Flow
-$100.0K
-100.4% YoY
Revenue Growth
-13.3%
EPS Growth
-148.1%
Gross Margin
7.7%
Net Margin
-0.3%
Income statement
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 876M | 1.0B | 1.0B | 969M | 937M |
| Gross Profit | 18M | 96M | 101M | 93M | 100M |
| Operating Income | 500K | 8M | 16M | 17M | 28M |
| EBITDA | 16M | 22M | 19M | 29M | 39M |
| Net Income | -2M | 5M | 10M | 11M | 20M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18M | 3M | 9M | 4M | 900K |
| Total Assets | 195M | 228M | 216M | 205M | 225M |
| Total Liabilities | 91M | 119M | 104M | 96M | 119M |
| Shareholder Equity | 104M | 109M | 112M | 108M | 106M |
| Total Debt | 72M | 77M | 64M | 63M | 71M |
| Net Debt | 54M | 74M | 56M | 59M | 71M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
7M
-72.0% YoY
Capital Expenditures
7M
-138.7% YoY
Free Cash Flow
100K
-100.4% YoY
Key ratios
Gross Margin
7.7%
Operating Margin
0.1%
Net Margin
-0.3%
ROE
-2.2%
Debt / Equity
0.69x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.